|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.96 - 2.09|
|52 Week Range||1.96 - 2.09|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The St. Paul, Minnesota-based company said it had a loss of $1.06 per share. The medical device company posted revenue of $360,000 in the period. The company's shares closed at $1.61. A year ago, they ...
Zacks.com highlights: Avon Products, Altria Group, EnteroMedics, Macquarie Infrastructure and Sibanye Gold
Express Scripts Holding Company (ESRX) posted robust first-quarter numbers driven by operational cost improvement backed by focus on technology, digital tools, home delivery and specialty services.
athenahealth (ATHN) witnessed a year-over-year increase in Q3 revenues on the back of strength in its Business and Services segment.
The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, SeaSpine Holdings and EnteroMedics
In view of the current political scenario and banking on favorable metrics, these four MedTech stocks stand out as the most suitable momentum picks.
EnteroMedics Inc (NASDAQ:ETRM), a healthcare equipment and services company based in United States, See our latest analysis for ETRM Is ETRM still cheap? Great news for investors – ETRM isRead More...
Categories: Yahoo FinanceGet free summary analysis EnteroMedics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of EnteroMedics, Inc. – LivaNova Plc, Boston Scientific Corporation, Misonix, Inc., NeuroMetrix, Inc., Natus Medical Incorporated, Johnson & Johnson, Medtronic plc and Abbott Laboratories (LIVN-US, BSX-US, MSON-US, NURO-US, BABY-US, JNJ-US, ... Read more (Read more...)
On a per-share basis, the St. Paul, Minnesota-based company said it had a loss of 91 cents. The medical device company posted revenue of $93,100 in the period. Its adjusted revenue was $93,000. The company's ...
On a per-share basis, the St. Paul, Minnesota-based company said it had a loss of $1.27. The medical device company posted revenue of $40,000 in the period. EnteroMedics shares have more than tripled since ...